Next Article in Journal
An Overview of the Development and Preclinical Evaluation of Antibody–Drug Conjugates for Non-Oncological Applications
Next Article in Special Issue
Progress in circRNA-Targeted Therapy in Experimental Parkinson’s Disease
Previous Article in Journal
Cholinium-Based Ionic Liquids as Promising Antimicrobial Agents in Pharmaceutical Applications: Surface Activity, Antibacterial Activity and Ecotoxicological Profile
Previous Article in Special Issue
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Article

Article Versions Notes

Pharmaceutics 2023, 15(7), 1808; https://doi.org/10.3390/pharmaceutics15071808
Action Date Notes Link
article xml file uploaded 24 June 2023 10:29 CEST Original file -
article xml uploaded. 24 June 2023 10:29 CEST Update https://www.mdpi.com/1999-4923/15/7/1808/xml
article pdf uploaded. 24 June 2023 10:29 CEST Version of Record https://www.mdpi.com/1999-4923/15/7/1808/pdf
article html file updated 24 June 2023 10:30 CEST Original file -
article html file updated 24 June 2023 10:31 CEST Update -
article html file updated 6 July 2023 21:46 CEST Update https://www.mdpi.com/1999-4923/15/7/1808/html
Back to TopTop